10-Q: Hillenbrand Reports Q1 2025 Results: Revenue Declines, But Margin Improves Amidst Strategic Shift

Hillenbrand's Q1 2025 net revenue decreased by 9% year-over-year, but gross profit margin improved by 70 basis points.

Summary

• Hillenbrand's net revenue for the first quarter of 2025 was $706.9 million, a decrease of 9% compared to $773.3 million in the same period of 2024.
• The Advanced Process Solutions segment saw a 10% decrease in net revenue, while the Molding Technology Solutions segment experienced a 5% decrease.
• Gross profit decreased by 6% to $235.0 million, but gross profit margin improved by 70 basis points to 33.2%.
• Operating expenses increased by 8% to $171.1 million, driven by higher business acquisition, divestiture, and integration costs.
• The company reported a pension settlement gain of $1.7 million compared to a charge of $8.3 million in the prior year.
• Net income attributable to Hillenbrand was $6.4 million, or $0.09 per share, compared to $17.2 million, or $0.25 per share, in the prior year.
• Adjusted EBITDA from continuing operations decreased by 15% to $97.1 million.
• The effective tax rate increased to 41.8% from 33.9% in the prior year.
• Backlog for Advanced Process Solutions decreased by 17% year-over-year to $1,583.6 million.
• The company expects the Milacron injection molding and extrusion business sale to close in the second or third quarter of 2025.
• The company had $653.3 million of borrowing capacity under its revolving credit facility, with $424.3 million immediately available.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While gross profit margin improved, revenue and earnings declined. The strategic divestiture of Milacron could be viewed positively, but overall, the results are somewhat disappointing.

Positives

• Gross profit margin improved by 70 basis points to 33.2%.
• The company reported a pension settlement gain of $1.7 million compared to a charge of $8.3 million in the prior year.
• The company expects to close the sale of an ownership stake in its Milacron injection molding and extrusion business in Q2 or Q3 2025 for $287.0 million.
• The company had $653.3 million of borrowing capacity under its revolving credit facility, with $424.3 million immediately available.

Negatives

• Net revenue decreased by 9% to $706.9 million.
• Advanced Process Solutions net revenue decreased $57.2 (10%), primarily driven by a decrease in volume, partially offset by favorable pricing.
• Molding Technology Solutions net revenue decreased $9.2 (5%), primarily driven by a decrease in injection molding and hot runner equipment sales.
• Operating expenses increased by 8% to $171.1 million, driven by higher business acquisition, divestiture, and integration costs.
• Net income attributable to Hillenbrand was $6.4 million, or $0.09 per share, compared to $17.2 million, or $0.25 per share, in the prior year.
• Adjusted EBITDA from continuing operations decreased by 15% to $97.1 million.
• Advanced Process Solutions backlog decreased by 17% year-over-year to $1,583.6 million.
• The effective tax rate increased to 41.8% from 33.9%.

Risks

• Global market and economic conditions could impact performance.
• Business disruptions associated with information technology, cyber-attacks, or catastrophic losses affecting infrastructure could occur.
• Increasing competition for highly skilled and talented workers, as well as labor shortages, could pose challenges.
• Increased costs, poor quality, or unavailability of raw materials or certain outsourced services and supply chain disruptions could impact results.
• Uncertainty in U.S. global trade policy and risks with governmental instability in certain parts of the world such as Germany could affect operations.
• Negative effects of acquisitions, including the Schenck Process Food and Performance Materials (FPM) business and Linxis Group SAS (Linxis) acquisitions, on the Company’s business, financial condition, results of operations and financial performance could occur.
• Competition in the industries in which we operate, including on price, could impact results.
• Cyclical demand for industrial capital goods could affect revenue.
• The ability to recognize the benefits of any acquisition or divestiture, including the Milacron injection molding and extrusion business sale (the Proposed Transaction), including potential synergies and cost savings or the failure of the Company or any acquired company, or the Proposed Transaction, to achieve its plans and objectives generally could impact results.
• Any failure by the parties to satisfy any conditions to the Proposed Transaction could prevent the transaction from closing.
• The possibility that the Proposed Transaction is ultimately not consummated could impact results.
• Potential adverse effects of the announcement or results of the Proposed Transaction on the market price of the Company’s common stock or on the ability of the Company to develop and maintain relationships with its personnel and customers, suppliers and others with whom it does business or otherwise on the Company’s business, financial condition, results of operations and financial performance could occur.
• Risks related to diversion of management’s attention from our ongoing business operations due to the Proposed Transaction could impact results.
• Impacts of decreases in demand or changes in technological advances, laws, or regulation on the net revenues that we derive from the plastics industry could occur.
• The impact to the Company’s effective tax rate of changes in the mix of earnings or in tax laws and certain other tax-related matters could occur.
• Exposure to tax uncertainties and audits could impact results.
• Involvement in claims, lawsuits, and governmental proceedings related to operations could occur.
• Uncertainty in the U.S. political and regulatory environment, including as a result of the U.S. presidential election and any proposed tariffs could impact results.
• Adverse foreign currency fluctuations could affect results.
• Labor disruptions could occur.

Future Outlook

The company expects the transaction to sell an ownership stake in its Milacron injection molding and extrusion business to close in the second or third quarter of 2025.

Management Comments

• Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements.

Industry Context

Hillenbrand operates in the global industrial sector, providing equipment and solutions to industries such as durable plastics, food, and recycling. The company's performance is influenced by factors such as global economic conditions, cyclical demand for industrial capital goods, and competition within these industries.

Comparison to Industry Standards

• It is difficult to provide a direct comparison to industry standards without specific competitor data.
• However, the document mentions that backlog is a common measurement used in industries with extended lead times for order fulfillment, like those in which Hillenbrand's reportable operating segments compete.
• The company's adjusted EBITDA margin can be compared to that of other industrial companies, but this would require further research and analysis.

Legal Proceedings

• From time to time, Hillenbrand is involved in claims, lawsuits, and government proceedings relating to its operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, product and general liability, workers compensation, auto liability, employment-related, and other matters.

Stakeholder Impact

• The results and strategic decisions outlined in the document could impact shareholders, employees, customers, suppliers, and creditors.
• The sale of Milacron, for example, will likely affect employees in that division and could lead to changes in relationships with customers and suppliers.

Next Steps

• The company expects to close the sale of an ownership stake in its Milacron injection molding and extrusion business in the second or third quarter of 2025.
• The company will continue to monitor plan funding levels, performance of the assets within the plans, and overall economic activity, and it may make additional discretionary funding decisions based on the net impact of the above factors.

Key Dates

Keywords

Hillenbrand, net revenue, gross profit, EBITDA, Advanced Process Solutions, Molding Technology Solutions, financial results, Q1 2025, earnings, backlog, divestiture, Milacron, acquisition